Loar Group buys General Ecology

By Luisa Beltran — 2 weeks ago

Loar Group Inc, a portfolio company of JLL Partners, has acquired General Ecology Inc. Financial terms weren’t announced. Exton, Pennsylvania-based General Ecology develops and produces water purification and micro-filtration systems for commercial and business aircraft under the Versa-Pure® brand as well as the worldwide residential, restaurant, portable, marine and recreational vehicle markets under the Seagull® and First Need® brands. BlackArch Partners advised General Ecology.

Continue

PE-backed BioClinica buys Synowledge

By Iris Dorbian — 5 months ago

BioClinica, which is backed by Water Street Healthcare Partners and JLL Partners, has acquired Synowledge. No financial terms were disclosed, Based in Miami, Florida, Synowledge is a pharmaceutical and biotech company.

Continue

PE-backed Patheon files for IPO

By Iris Dorbian — 8 months ago

Durham, North Carolina-based Patheon, a provider of outsourced pharmaceutical development and manufacturing services, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. J.P. Morgan, Morgan Stanley, Jefferies and UBS are serving as the lead underwriters. Patheon is owned by JLL Partners and Royal DSM.

Continue

Sun Capital exits Point Blank

By Iris Dorbian — 9 months ago

Sun Capital Partners has sold its stake in Point Blank Enterprises to JLL Partners. No financial terms were disclosed. Based in Pompano Beach, Florida, Point Blank is a maker of ballistic and soft armor systems.

Continue

JLL Partners and Royal DSM complete Dpx Holdings transaction

By Angela Sormani — 2 years ago

JLL Partners and Royal DSM, a global life sciences and materials sciences company have closed the transaction announced in November 2013 combining DSM Pharmaceutical Products and Patheon Inc into a new privately held company named DPx Holdings. With headquarters in Durham, N.C., DPX’s global footprint includes 24 global locations across North America, Europe, Latin America and Australia.

Continue

BioClinica and CoreLabs Merged into BioClinica

By Connie Loizos — 3 years ago

After their purchase of BioClinica, a clinical train management services firm, and the medical imaging and cardiac safety services company CoreLab Partners, middle market firms JLL Partners and Ampersand Capital Partners have combined the two companies under the name BioClinica.

Continue

BioClinica Announces Its Tender Offer is Complete

By Connie Loizos — 3 years ago

BioClinica, a Newton, Pa.-based clinical trials management company, and JLL Partners, a New York private equity firm, announced that they’ve successfully completed the tender offer by BC Acquisition Corp., an affiliate of JLL Partners that last month began a $7.25 per share offer for all outstanding shares of BioClinica. In January, JLL agreed to acquire BioClinica for $123 million.

Continue

Tender Offer Commences for BioClinica

By Angela Sormani — 3 years ago

BioClinica and JLL Partners have announced that BC Acquisition Corp has commenced a tender offer for all outstanding shares of BioClinica at a price of $7.25 per share net to the seller in cash. BioClinica is a provider of clinical trial management solutions.

Continue

JLL Partners Completes American Dental Deal

By Jonathan Marino — 4 years ago

JLL Partners, the New York-based private equity firm, completed its acquisition of American Dental Partners, the Massachusetts-based dental group practice with operations in 21 states. Specifics of the deal were not publicized; JLL’s Michael Lagarde, a managing director with the firm, worked on the transaction. PRESS RELEASE: JLL Partners, Inc. (“JLL”) and American Dental Partners, […]

Continue

HealthCor Partners Out Seeking $300M For Fund II

By David M. Toll — 4 years ago

HealthCor Partners Management, an investor in fast-growing health care and life sciences companies, is out seeking $300 million—a tally that would double the firm’s assets under management if achieved. The New York-based firm is part of the HealthCor Group, a hedge-fund manager and private equity shop with more than $3 billion under management. According to […]

Continue